ClinicalTrials.Veeva

Menu

Strontium Ranelate and KOA

M

Mansoura University

Status

Completed

Conditions

Knee Osteoarthritis

Treatments

Drug: Strontium Ranelate
Other: physiotherapy

Study type

Interventional

Funder types

Other

Identifiers

NCT03937518
MS 15.09.44

Details and patient eligibility

About

The present study was carried out on thirty patients with primary knee osteoarthritis. Patients were recruited from Rheumatology and Rehabilitation

Outpatient Clinic at Mansoura University Hospi Patients were divided into two groups:

Group 1: included 15 patients who received oral strontium ranelate and physiotherapy program. The age of the patients ranged from 50 to 62 years, they were 11 females and 4 males. Group 2: included 15 patients who received physiotherapy program. The age of the patients ranged from 50 to 62 years, they were 12 females and 3 males. Written consent was obtained from each participant sharing in the study. This study was approved by the institution research board of faculty of medicine, Mansoura University, code: MS/15.10.08. Inclusion

Full description

The present study was carried out on thirty patients with primary knee osteoarthritis. Patients were recruited from Rheumatology and Rehabilitation

Outpatient Clinic at Mansoura University Hospi Patients were divided into two groups:

Group 1: included 15 patients who received oral strontium ranelate and physiotherapy program. The age of the patients ranged from 50 to 62 years, they were 11 females and 4 males. Group 2: included 15 patients who received physiotherapy program. The age of the patients ranged from 50 to 62 years, they were 12 females and 3 males. Written consent was obtained from each participant sharing in the study. This study was approved by the institution research board of faculty of medicine, Mansoura University, code: MS/15.10.08.

InclusionAll patients were subjected to the following:

I. History Taking :

  1. Personal History

    • Name, age, sex, residence, marital status.
    • Occupational status.
    • Special habits e.g. smoking status (current/previous).
  2. Complaint:

    Taken in the patient's own words with special stress on disease duration.

  3. Present history:

    Onset, course and duration of disease. Analysis of complaint Pain: type of pain, site of pain, factors participating/alleviating pain. Swelling. Crepitus. Limitation of movement. Morning and inactivity stiffness, its duration and location. Other joints affected and its pattern of distribution.

    History of other systems affections:

    Neurological symptoms (muscle power and sensation of the lower limbs). Eye symptoms (redness, ulcers and blurred vision). Gastrointestinal tract (GIT) symptoms (diarrhea, heart burn and mucus in the stool). Urinary tract (UT) symptoms (dysuria and frequency). Skin affection (ulcers, erythema, papules and nodules).

  4. Past history:

History of surgical operation of knee.

HistoryAssessment of range of motion of the affected knee joint:

For any limitation in the range of motion of the knee joint.

D) Special tests to assess ligaments and menisci:

Varus stress test for lateral collateral ligament. Valgus stress test for medial collateral ligament. Anterior drawer test for anterior cruciate ligament. Posterior drawer test for posterior cruciate ligament.

McMurry's test for menisci.Radiological investigations:

Enrollment

30 patients

Sex

All

Ages

50 to 62 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Patients aged ≥ 40 years with symptoms of knee osteoarthritis

Exclusion criteria

rheumatoid arthritis, spondyloarthropathy

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Sequential Assignment

Masking

None (Open label)

30 participants in 2 patient groups

strontium ranelate
Other group
Description:
included 15 patients who received oral strontium ranelate and physiotherapy program. The age of the patients ranged from 50 to 62 years,
Treatment:
Drug: Strontium Ranelate
Other: physiotherapy
physiotherapy
Other group
Description:
included 15 patients who received physiotherapy program. The age of the patients ranged from 50 to 62 years
Treatment:
Other: physiotherapy

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems